Johan Kördel

Ph.D., Managing Partner
Johan Kördel Ph.D., Managing Partner - Sound Bioventures

Ph.D. Managing Partner

Prior to founding Sound Bioventures, Johan was a Senior Partner at Lundbeckfonden Ventures where he worked for 12 years, and led investments and served as a member of the board of directors in companies including: Acacia Pharma (Euronext: ACPH), Amplyx (sold to Pfizer), Bonesupport (OMX: BONEX), Celladon (Nasdaq: CLDN), Curzion (sold to Horizon), Reneo Pharma (Nasdaq: RPHM), River Vision (sold to Horizon), Syntaxin (sold to Ipsen), VHSquared (sold to Sorisso Pharma) and Ziarco (sold to Novartis).

Before this Johan worked in the Pharmaceutical and Biotech industry for 20 years. One of the three biotech companies Johan has co-founded is Biovitrum (OMX:SOBI) where he led Business development and the Research division. He also worked for a decade at Pharmacia with Research, Portfolio and Project management and through three large mergers.

Malmö, SE, office.

Read an interview with Johan Kördel